Navigation Links
Roche in Medical News

Enigma Diagnostics Announces Signing of Patent Licenses With Roche Molecular Systems, Inc.

PORTON DOWN, England, July 16 /PRNewswire/ -- Enigma Diagnostics Limited, the decentralized and point-of-care molecular diagnostics company, announced today that it has signed two patent license agreements with Roche Molecular Systems, Inc. (RMS). The licenses signed on 15 July 2009,...

Raptor Pharmaceuticals to Collaborate with Roche on Therapeutic Delivery Across Blood-Brain Barrier

Roche to fund evaluation of Raptor's proprietary NeuroTrans(TM) technology NOVATO, Calif., June 9 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP), today announced that it has entered a collaboration and licensing agreement with Roc...

moksha8 Expands Alliance With Roche to Commercialize $200 Million of Products in Brazil and Mexico

MEXICO CITY, SAO PAULO and PHILADELPHIA, May 20 /PRNewswire/ -- moksha8, Inc. announced today that it has expanded its strategic partnership with Roche to commercialize an additional portfolio of products in Mexico currently generating sales of $140 million USD. moksha8 will commercialize pr...

Corporate Pandemic Preparedness Experts from Roche & PSEG to Advise Savvy Business Leaders May 15

CHAPEL HILL, N.C., May 7 /PRNewswire/ -- When the unpredictable influenza season returns in the fall, health care officials warn that the seemingly lessening threat of the H1N1 outbreak may worsen. Operating under pandemic contingency plans already, nearly one-third of companies do not have a po...

Gen-Probe, Roche Prevail in Arbitration With Digene Concerning Human Papillomavirus Agreement

SAN DIEGO, April 1 /PRNewswire-FirstCall/ -- Gen-Probe (Nasdaq: GPRO ) announced today that the Company, along with its co-respondents F. Hoffmann-La Roche Ltd. and Roche Molecular Systems, Inc., has prevailed in its arbitration with Digene (now Qiagen) concerning the Company's supply and purcha...

University Medical Pharmaceuticals Appoints Tom Roche as Senior Vice President, Global Sales and Marketing

Beauty Care Sales and Marketing Veteran to Drive International Retail Expansion, With Near Term Focus on Top Selling AcneFree Product Group and New WrinkleFree Brand Line Extension IRVINE, Calif., Jan. 21 /PRNewswire/ -- University Medical Pharmaceuticals, a leading developer and distributo...

More>>

Roche in Medical Technology

ThromboGenics and BioInvent Receive Technology Transfer Success Fee From Roche for the Novel Anti-Cancer Antibody, TB-403 (Anti-PIGF)

LEUVEN, Belgium and LUND, Sweden, January 26 /PRNewswire-FirstCall/ -- ThromboGenics NV (EURONEXT:THR) and BioInvent International AB (OMXS:BINV) announce today that they have received a technology transfer success fee of EUR5 million from Roche under the terms of their strategic alliance for ...

Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target

SAN DIEGO, Dec. 8 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO ), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced that Roche has dosed the first patient in a Phase 1 pharmacokinetic clinical trial with...

Memory Pharmaceuticals and Roche Expand R3487/MEM 3454 Development Program

- Amendment Results in Accelerated Payments of $8.5 Million - MONTVALE, N.J., Sept. 17 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (Nasdaq: MEMY ) today announced that it has amended its nicotinic alpha-7 receptor agonist agreement with Roche to expand the Phase 2 development ...

National Jewish Health and Roche Diagnostics Corporation Reach Agreement to Pursue Environmental Molecular Diagnostics Opportunities

DENVER, Sept. 10 /PRNewswire-USNewswire/ -- National Jewish Health and Roche Diagnostics Corporation have reached a strategic agreement to pursue opportunities in the growing field of molecular diagnostics. This partnership will combine National Jewish's expertise in clinical testing and care ...

New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients

BASEL, Switzerland, May 15 /PRNewswire/ -- Patients with breast or colorectal cancer, two of the world's most common cancers, can expect further treatment advances with Avastin(R) (bevacizumab) and Herceptin(R) (trastuzumab) following new data that is being presented at the 44th American Socie...

Memory Pharmaceuticals & Roche Expand Development Program for MEM 3454 in Schizophrenia

- Establishes Plan for Biomarker Study - MONTVALE, N.J., Feb. 19 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (Nasdaq: MEMY ) today announced that it plans to conduct a clinical study of MEM 3454, the Company's lead nicotinic alpha-7 partial agonist, on two biomarker...
Roche in Medical Products

Microbumin Microalbumin Control

Description:... Microbumin is a two-level control compatible with popular strips such as Clinitek Microalbumin Reagent Strips and roche Micral test strips. This control is also suitable for turbidimetric immunoassays using AU Series, Bayer Clinitek 50, 100 and DCA 2000, Cobas, Diasorin...
Company:Quantimetrix Corporation

CARDIAC proBNP Test

Description:... The roche CARDIAC proBNP assay is a rapid and accurate bedside test for the easy to u...oth speed and accuracy profit from a test combining speed (measuring time roche CARDIAC proBNP assay = 12 minutes. In emergency departments Point of Care T...
Company:Roche Diagnostics

Roche COMPACT 3 Blood Gas Analyzer

Description:...fastest blood gas analyzers for critical and intensive care situations on the market. Equally suitable for neonatology and lung function testing. The roche COMPACT 3 offers a quick and reliable assessment of acid-base status and oxygen supply from whole blood, plasma or serum....
Company:Roche Diagnostics

Roche OMNI S Blood Gas Analyzer

Description:... roche OMNI S is the next generation Critical Care Analyzer completes and extends the roche product portfolio for Hospital Point of Care applications. The modular conc...
Company:Roche Diagnostics

LightCycler 2.0 Instrument

Description:... The LightCycler 2.0 System is the newest real-time PCR instrument offered by roche Applied Science. This new instrument offers six detection channels that provide fluorescence detection at 530, 560, 610, 640, 670, and 710nm. Perform ...
Company:Roche Applied Science

Emit® 2000 (Convenience Pack) Phenytoin Assay

Description:... enzyme immunoassay intended for use in the quantitative analysis of phenytoin in human serum or plasma. Kits are packaged specifically for use on the roche COBAS MIRA, COBAS MIRA S, and COBAS MIRA Plus chemistry systems...
Company:Dade Behring, Inc.

More>>

Roche in Biological News

Washington University increases fleet of Roche Genome Sequencer FLX Systems

INDIANAPOLISThe Genome Sequencing Center at Washington University School of Medicine increased its sequencing capacity with an agreement to acquire five additional Genome Sequencer FLX Systems from Roche Diagnostics. With a total of eight Genome Sequencer FLX Systems, the Genome Sequencing Cent...

Scientists decoding genomic sequences of H1N1 using isolates from outbreak in Argentina

...are working with Argentina's National Institute of Infectious Diseases, the National Administration of Laboratories and Health Institutes (ANLIS), and roche 454 Life Sciences to decode the complete genomic sequences of influenza pandemic (H1N1) 2009 virus from patients with severe respiratory disease. The ...

Landmark project to map genomics of complex ant systems

... Giga-base Grant Program for DNA sequencing and transcriptome analysis from roche Applied Sciences, Gerardo put together a project to not only sequence ant g...ing, and one ancient, more primitive species. Entering new territory roche will sequence the DNA using its proprietary high-throughput genome sequenci...

Another JDRF partner moves research forward with collaboration agreement for diabetes treatment

...stry partner Bayhill Therapeutics Inc., based in California, entered into a collaboration agreement with Genentech, Inc., a wholly owned member of the roche Group, to further develop and potentially commercialize a novel antigen-specific immunotherapeutic designed to reverse the immune response that causes...

Rapid approach to identify influenza A virus mutations and drug resistance developed

..., Development and Research), in collaboration with roche NimbleGen. The system, which combines a novel g...virus is evolving," said Gerd Maass, Ph.D., CEO of roche NimbleGen. GIS scientists used NimbleGen array...source and to globally monitor the SARS virus. roche NimbleGen's custom-developed microarrays: The ...

CHIs 5th Biomarker World Congress: Signature Event with Cutting-Edge Agenda

...ee Foernzler, Ph.D., Biomarker-Experimental Medicine Leader, F. Hoffmann-La roche AG Alberto Gutierrez, Ph.D., Deputy Director, Office of In Vitro Dia...P.H., Head, Medical Genomics & Vice President, Research, F. Hoffmann-La roche AG Helen M. Moore, Ph.D., Director, Biospecimen Research Network, Na...
Roche in Biological Technology

Exosome Diagnostics Appoints Former Roche Executive Greg Zdechlik as Chief Operating Officer

Zdechlik was Founding member of the U.S. Clinical Molecular Diagnostic Group NEW YORK, July 23 /PRNewswire-USNewswire/ -- Exosome Diagnostics, Inc., the developer of non-invasive molecular oncology diagnostics to aid in early cancer detection and therapeutic selection, announc...

Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement

MADISON, Wis., July 1 /PRNewswire/ -- Cellular Dynamics International (CDI) and Roche announced today a significant expansion of their existing agreement to test drug development candidates for their potential to cause cardiotoxicity, or damage to heart tissue. The two-year collaboration a...

BioDuro and Roche Expand Strategic Collaboration to Provide Drug Discovery Services

BEIJING, April 6 /PRNewswire/ -- BioDuro announced today that they have entered into a strategic partnership with Roche to support discovery phase research efforts at Roche's global research sites. BioDuro will provide research services in the areas of discovery chemistry and biology, which can he...

Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors

BETHESDA, Md., Feb. 23 /PRNewswire/ -- Micromet, Inc. (Nasdaq: MITI ), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that Dr. Kapil Dhingra has joined its Board of Directors, effective as ...

Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients

PRINCETON, N.J., Jan. 12 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS ) announced today that they and their development partner, Roche, have agreed with the FDA on the final design for a phase 2b trial with R7128, a nucleoside inhibitor of hepatitis C (HCV), slated to initiate in the...

Axial Biotech Appoints Retired Roche Diagnostics Executive to Board

Experienced leader will provide commercialization expertise to company SALT LAKE CITY, Oct. 14 /PRNewswire/ -- Axial Biotech, Inc., a company revolutionizing spine care through the development of molecular diagnostic technologies, announced today the appointment of William L. Lister as the ne...
Roche in Biological Products

In Situ Cell Death Detection Kit, Fluorescein from Roche Applied Science

Description: ...
Company:Roche Applied Science

MagNA Pure LC Instrument from Roche Applied Science

Description: ...
Company:Roche Applied Science

SYBR Green I Nucleic Acid Gel Stain from Roche Applied Science

Description: ...
Company:Roche Applied Science

GC-RICH PCR System from Roche Applied Science

Description: ...
Company:Roche Applied Science

GC-RICH PCR System from Roche Applied Science

Description: ...
Company:Roche Applied Science

Propidium iodide; solution (Available only in the U.S.) from Roche Applied Science

Description: ...
Company:Roche Applied Science

More>>

Roche in Biological Definition

Monoclonal antibody

...7. ^ ORTHOCLONE OKT 3 Information page at Ortho Biotech . Retrieved 2005-03-10. ^ ZENAPAX (daclizumab) Information page at roche Pharmaceuticals . Retrieved 2005-03-10. ^ Novartis product page for Simulect (basiliximab for injection) . Retrieved 2005-03-09. ...

Polymerase chain reaction

...everal high-profile lawsuits related to the technique, including most famously a lawsuit brought by DuPont . The pharmaceutical company Hoffmann-La roche purchased the rights to the patents in 1992 and currently holds them. PCR in practice Figure 1 : PCR machine PCR is used to...
Roche in Biological Dictionary

Transfection

...NA, siRNA or duplex RNAi, oligonucleotides, and RNA into eukaryotic cells for a ... More information on Cutting Edge Transfection Reagents from roche Applied Science ... Web Seminar—Challenges and Transfection Technologies in the Study of Cellular ... Transfection summary with 4 pages of ency...

Restriction enzymes

...es for restriction enzymes , a.k.a. restriction endonucleases, in DNA sequences. ... With more than 115 restriction enzymes now available, roche Applied Science provides. restriction enzymes that span a wide range of recognition sequences, ... We tested 30 popular Promega restriction ...

Reporter Gene

...ion and genetic ... From our vast line of reporter gene assays, you can choose ... A sample of the reporter gene assay kits available from roche Molecular Biochemicals. ... Reporter Genes and Proteins ... reporter proteins in use: b-galactosidase (encoded by the bacterial gene lacZ...
Other Tags
(Date:9/1/2015)... ... September 01, 2015 , ... ... information about new patients directly from Practice Perfect to FOTO enabling cost and ... , Steven Presement, President of Practice Perfect, stated "FOTO is ...
(Date:9/1/2015)... ... September 01, 2015 , ... Routines… every family has them. Whether ... make things easier for parents, caregivers and children too. Here are three reasons why ... and small become more fluid. When a routine is implemented into a child’s schedule, ...
(Date:9/1/2015)... ... September 01, 2015 , ... Specialty Technical Publishers (STP) and ... Protocol Consortium (IAPC) EHS audit protocol for the European Union. Leading companies around ... EHS regulatory obligations and rapidly collect, share, archive, and export audit findings in ...
(Date:8/31/2015)... TN (PRWEB) , ... September 01, 2015 , ... The ... and other clinically relevant measures for physical therapy patients. The Registry is being developed ... of FOTO, Inc. stated "We are happy to be selected to contribute FOTO Outcomes ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... potential patients the resources they need to have a successful cosmetic procedure; from ... plastic surgeons; Cosmetic Town Journal is always ready to help. , It is ...
Breaking Medicine News(10 mins):Health News:FOTO Announces New Integration Partnership with Practice Perfect 2Health News:Back into the Swing of Things: How Family Routines Benefit Children 2Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 2Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 3Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 4Health News:FOTO Selected as Official Registry Partner with Physical Therapy Outcomes Registry 2Health News:Cosmetic Town: A One Stop Plastic Surgery Community 2
(Date:8/11/2015)... 11, 2015 Today, ZUK announced its Android ... well as expected revenues in 2015 that relate to sales of ... guidance of approximately 2,200 MSEK for 2015. Jörgen Lantto, ... prominent smartphone manufacturer in China ... selected FPC1 155 for Z1 ...
(Date:8/6/2015)... , Aug. 6, 2015 Synaptics ... of human interface solutions, today announced collaboration with ... on Windows 10. Microsoft leveraged Synaptics, deep expertise ... operating system. Through stringent testing, ... fully certified with Microsoft,s Precision TouchPad (PTP) specification ...
(Date:8/4/2015)... ALBANY, N.Y., Aug. 4, 2015  AMRI (NASDAQ: AMRI ) ... June 30, 2015. Highlights: , Second quarter ... increase from 2014 , Adjusted contract margins of ... EPS of $0.22, including a $0.05 decrease in EPS from royalties ... of $16 million "We are very pleased to ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2Synaptics Chosen for Human Interface Co-Development on Windows 10 2AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24
Other Contents